761 vs NP5: Side-by-Side Comparison
Compare PHARMANUTRA S.P.A. (761) and NEWRON PHARMACEUT. EO-20 (NP5) side by side: market cap EUR 822.51M vs EUR 281.92M. Financials, growth and model signals on Bullrun.
| Metric | 761 | NP5 |
|---|---|---|
| Company | PHARMANUTRA S.P.A. | NEWRON PHARMACEUT. EO-20 |
| Country / Exchange | Italy · F | Italy · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
| Market cap | EUR 822.51M | EUR 281.92M |
| P/E ratio | 39.0 | — |
| Dividend yield | 1.40% | — |
| Valuation model | 0.9% undervalued | — |
| Revenue (FY2025) | EUR 131.69M | EUR 19.13M |
| Revenue growth YoY | +14.0% | -62.8% |
| Net income | EUR 20.00M | EUR -13.24M |
| Gross margin | — | — |
| Diluted EPS | 2090.00 | -0.66 |